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Inﬂammatory myoﬁbroblastic tumor (IMT) is a rare benign lesion found in many locations throughout
the body and genitourinary tract. Endoscopically and radiographically, these solid lesions cannot be
distinguished from malignant bladder tumors. We present the case of a 21-year-old woman who pre-
sented with painful obstructive and irritative voiding symptoms of short duration. After extensive pre-
operative evaluation failed to reveal a deﬁnitive diagnosis, the patient underwent partial cystectomy.
Final pathology revealed IMT. A high index of suspicion is required for diagnosis of IMT as it is often
difﬁcult to distinguish from its malignant counterparts.
 2014 The Authors. Published by Elsevier Inc. All rights reserved.Introduction
Inﬂammatory myoﬁbroblastic tumor (IMT) is a rare benign
lesion found in many locations throughout the body and genito-
urinary tract. Endoscopically and radiographically, these solid le-
sions cannot be distinguished from malignant bladder tumors.
Diagnosis is based on full resection with histologic evaluation of
atypical spindle cell proliferations. We present the case of a 21-
year-old woman who presented with painful obstructive and irri-
tative voiding symptoms of short duration. The case and literature
review, including presentation, radiographic and histologic ﬁnd-
ings, and management, are presented.
Case presentation
A 21-year-old G0P0 woman presented to our clinic with severe
dysuria, pressured voiding, urgency, and hourly urinary frequency
of 3-week duration. She denied fevers, chills, sweats, nausea, and
vomiting. She described severe dysuria and low abdominal and
perineal pain after micturition. She had no signiﬁcant urologic
history. She was referred with a positive pyridium tampon test (this
would indicate a ﬁstula) and difﬁculty with passage of a Foley
catheter for urine culture when she was unable to void. PhysicalBY-NC-ND license (http://
ty of Kansas Medical Center,
: þ1-913-588-7625.
Published by Elsevier Inc. All righexamination revealed a mildly overweight woman appearing in
good health. She was afebrile and hemodynamically stable. Pelvic
examination was signiﬁcant for left forniceal tenderness and urine
appearing ﬂuid in the introitus. Her laboratory workup was unre-
markable. In-ofﬁce ﬂexible cystoscopy revealed fullness of the left
bladder wall including benign-appearing cystic edematous
changes. Vaginogram and voiding cystourethrogram did not reveal
a ﬁstula, but were remarkable for a left, lateral bladder base ﬁlling
defect. Computed tomography (CT) urogram revealed eccentric
mural thickening of the left bladder base with varicoid enhance-
ment and extravesical stranding surrounding the left fallopian tube
(Fig. 1). A delayed left nephrogram was present on a scout ﬁlm
(Fig. 2). A CT-guided percutaneous needle biopsy was performed,
which revealed benign smooth muscle.
The patient was counseled on the differential including
benign and malignant pathologies. She was subsequently taken
for the operating room for exploratory laparotomy with resection
of the mass. Examination of the bladder revealed extensive
grape-like lesions involving the mucosa of the left bladder wall,
base, and trigone. The left ureteral oriﬁce was unable to be
visualized. Through a midline incision, multiple open bladder
biopsies were sent from the involved region. Initial pathologic
diagnoses included both normal urothelium and inverted uro-
thelial papilloma. A 2-cm, full-thickness, solid mass was palpated
at the left lateral bladder base in close proximity to the left
trigone. Left ureteral access was obtained and a stent was placed.
A partial cystectomy was performed and the lesion was resected
in its entirety. Gross specimen consisted of a tan-pink rubbery
tissue measuring 2.5  2.1  2.0 cm. Acute and chronic inﬂam-
mation with benign-appearing spindle cells (Fig. 3) was found,ts reserved.
Figure 1. Contrast-enhanced computed tomography during venous phase shows
nodular enhancing mass in the left lower bladder with perivesicular soft tissue fat
stranding on the left. Figure 3. Spindle cells within ﬁbromyxoid matrix and scattered inﬂammatory cells.
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for calponin and smooth muscle actin and focally positive for
desmin.Discussion
IMT is a rare benign lesion found in many places throughout
the body and genitourinary tract. IMT was originally described by
Roth in 1980. Dr. Roth presented a case in which a 32-year-old
woman was found to have an intravesical lesion composed of
spindle cells in a myxoid stroma, with scattered chronic inﬂam-
matory cells. The lesion was resected in its entirety without
recurrence.1
IMT has many designations including inﬂammatory pseudotu-
mor, inﬂammatory pseudosarcomatous ﬁbromyxoid tumor,
nodular fasciitis, pseudosarcomatous myoﬁbroblastic tumor, and
ﬁbromyxoid pseudotumor.2 IMT most commonly occurs in the
lungs but has been described in multiple organs including bladder,
liver, colon, spleen, and heart. Although some studies have reported
that this entity primarily occurs in young females, others have
shown no sex or age predilection.3 Presentation of bladder IMT
most commonly involves painless hematuria, dysuria, frequency,
and urgency.2
Imaging often provides no beneﬁt in differentiating IMT from
its malignant counterparts. Although most IMTs present asFigure 2. Delayed “scout” view from computed tomography shows nodular mass
involving the left bladder base and mild left hydroureter.intramural lesions without necrosis or perivesical lymphadenop-
athy, Kim, et al described a mass that was broad based with an
enhancing centrally necrotic core involving the bladder wall.
Perivascular extension to other pelvic structures appeared to be
present on CT.4
Histologic appearance is the mainstay of diagnosing IMT. It often
reveals a proliferation of spindle cells, which show no atypia, mild
nuclear pleomorphism, and rare mitotic activity with diffuse inﬁl-
tration of acute and chronic inﬂammatory cells, speciﬁcally lym-
phocytes, eosinophils, and macrophages. Immunohistochemical
staining often provides little assistance in diagnosis as similar
malignant lesions such as leiomyosarcoma, rhabdomyosarcoma,
and sarcomatoid transitional cell carcinoma have similar re-
activities. Several recent studies have investigated the use of
anaplastic lymphoma kinase (ALK) in the diagnosis of IMT. This is
the result of chromosomal translocation of the ALK gene (chro-
mosome 2p23) with a partner gene. These studies have reported
positive ALK-1 staining in 30%-75% of IMTs.5 Although this rate is
widely variable, only lymphoma has previously been shown to
express ALK-1.
Current standard treatment of IMT is complete surgical resec-
tion via either a transurethral approach if possible or an open
procedure. Although care should be taken to appropriately counsel
patients preoperatively regarding surgical therapies including
partial and radical cystectomy with urinary diversion, it is impor-
tant to recognize IMT and perform an organ-sparing procedure if
possible. IMT has not been shown to respond to chemotherapy or
radiotherapy. Alternative treatments are currently being investi-
gated and include both anti-inﬂammatory agents and anti-tumor
necrosis factor-a binding antibodies. Although early results are
promising, larger prospective studies are needed.
Conclusion
In summary, IMT is a rare benign tumor that can present in the
bladder. A high index of suspicion is required for diagnosis as it is
often difﬁcult to distinguish from its malignant counterparts. Sur-
gical resection is the treatment of choice and care should be taken
to appropriately counsel patients preoperatively regarding poten-
tial surgical therapies including the need for possible radical cys-
tectomy and urinary diversion. New therapies are on the horizon;
however, larger prospective studies are needed before these can be
widely adopted.
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